Skip to content

Preclinical, translational study about the differences in peritoneal stem cells in women with and without adhesions after gyneocological surgery

Preclinical, translational study about the differences in peritoneal stem cells in women with and without adhesions after gyneocological surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00010877
Enrollment
40
Registered
2023-05-25
Start date
2016-12-16
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N73.6 N99.4

Interventions

Group 1: The CD90 cell population is identified in peritoneal, adhesion, and omentum specimens from adult patients undergoing gynecologic surgery for benign gynecologic disease. Intraoperatively, a m

Sponsors

Forschungspool der Carl - von - Ossietzky Universität Oldenburg
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Woman equal to and above 18 years of age. Woman with a negative pregnancy test at the time of recruitment Woman with any gynecological pathology requiring scheduled pelvic gynecological surgery, either laparotomy or laparoscopy. Woman without primary peritoneal disease, other than adhesions.

Exclusion criteria

Exclusion criteria: Woman with a primary peritoneal pathology. Emergency surgery Patients under systemic immunosuppressive therapy in the previous 6 months Patients with current intra-abdominal or pelvic abscess or systemic infection Pregnant woman Simultaneous participation in another clinical trail

Design outcomes

Primary

MeasureTime frame
Our primary objective will be the identification of the CD90 cellpopulation in peritoneum, adhesion and omentum by histologic expression of CD90.

Secondary

MeasureTime frame
Secondly, we want to show the stem cell like multipotency of these cells by expression of CD31 and CD71 markers. Thirdly, we want to characterize the cells’ wound healing potential through the expression of the EPO receptor and beta-cr subunit via next gen sequencing.

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026